tiprankstipranks
Amphastar Pharmaceuticals Inc (AMPH)
:AMPH
US Market

Amphastar Pharmaceuticals (AMPH) Income Statement

Compare
399 Followers

Amphastar Pharmaceuticals Income Statement

Last quarter (Q3 2024), Amphastar Pharmaceuticals's total revenue was $188.82M, an increase of 4.58% from the same quarter last year. In Q3, Amphastar Pharmaceuticals's net income was $40.43M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 644.39M$ 498.99M$ 437.77M$ 349.85M$ 322.36M
Gross Profit
$ 351.12M$ 248.86M$ 199.74M$ 143.34M$ 131.92M
Operating Expenses
$ 154.13M$ 141.36M$ 129.85M$ 132.39M$ 131.96M
Depreciation and Amortization
$ 41.78M$ 28.74M$ 26.75M$ 25.18M$ 21.12M
EBITDA
$ 240.29M$ 107.50M$ 111.78M$ 30.19M$ 81.47M
Operating Income
$ 196.99M$ 78.76M$ 43.13M$ -14.23M$ -39.00K
Other Income/Expenses
$ -25.63M$ 8.54M$ 14.25M$ -6.32M$ 60.27M
Pretax Income
$ 171.36M$ 116.04M$ 84.14M$ 4.64M$ 60.23M
Net Income
$ 137.54M$ 91.39M$ 62.12M$ 1.10M$ 48.94M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 2.85$ 1.88$ 1.30$ 0.02$ 1.04
Diluted EPS
$ 2.60$ 1.74$ 1.25$ 0.02$ 0.98
Weighted Average Shares Outstanding
48.27M 48.55M 47.78M 47.04M 46.98M
Weighted Average Shares Outstanding (Diluted)
53.00M 52.43M 49.78M 49.12M 49.91M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis